Mounjaro and HRT: Can You Take Tirzepatide with Hormone Replacement Therapy?

Women's Health

26 October 2026

Woman in her late forties at a calm modern clinic consultation, discussing Mounjaro and HRT with her doctor

Mounjaro (tirzepatide) and hormone replacement therapy are two of the most commonly prescribed treatments for women navigating the perimenopause and menopause years. If you are taking HRT to manage hot flushes, night sweats, or bone protection and you are also considering Mounjaro for weight management, you will understandably want to know whether the two treatments are safe to use together. In this guide, a CutKilo doctor explains what the current evidence shows, how tirzepatide may interact with oral HRT, and why the combination may actually produce better weight-loss outcomes than tirzepatide alone.

Understanding how these treatments work alongside each other is particularly important because menopausal weight gain is driven by hormonal shifts that standard calorie restriction often cannot fully address. Furthermore, both treatments affect overlapping metabolic pathways, which makes getting clear clinical guidance essential.

Quick Answer: Can You Take Mounjaro with HRT?

Yes. There is no absolute contraindication to using tirzepatide alongside hormone replacement therapy. However, if you are taking oral HRT (tablets), tirzepatide’s effect on gastric emptying may reduce how quickly and how much oestrogen your body absorbs. Transdermal HRT (patches, gels, or sprays) bypasses the digestive system entirely and is therefore unaffected. A 2026 retrospective study published in The Lancet found that postmenopausal women using both tirzepatide and HRT lost approximately 35% more weight than those using tirzepatide alone. Your prescriber should review your HRT delivery method when starting Mounjaro, and transdermal options may be preferable during the dose-escalation phase.

Why Menopause Makes Weight Loss Harder

The decline in oestrogen during perimenopause and menopause triggers a redistribution of body fat from the hips and thighs towards the abdomen. This central adiposity is not simply a cosmetic concern. Visceral fat, which accumulates around the internal organs, is metabolically active tissue that increases insulin resistance, raises inflammatory markers, and elevates cardiovascular risk. In addition, falling oestrogen levels reduce resting metabolic rate by an estimated 50 to 100 kilocalories per day, making weight maintenance progressively more difficult even when dietary habits remain unchanged.

Moreover, menopausal symptoms such as disturbed sleep, low mood, and fatigue can make it harder to maintain the exercise routines and dietary discipline that support weight management. Consequently, many women find that the approaches which worked in their thirties are no longer effective after 45.

How HRT and Tirzepatide Work on Different Pathways

HRT restores circulating oestrogen (and sometimes progesterone) to levels that alleviate vasomotor symptoms, protect bone density, and help reverse the unfavourable shift in fat distribution. Specifically, oestrogen appears to preserve insulin sensitivity and may support the brain’s appetite-regulating signals in the hypothalamus.

Tirzepatide, by contrast, is a dual GIP and GLP-1 receptor agonist. It reduces appetite through direct central nervous system effects, slows gastric emptying so you feel fuller for longer, and improves insulin sensitivity and glucose handling. In the SURMOUNT clinical programme, perimenopausal women achieved approximately 20 to 23% total body weight loss, comparable to results in younger cohorts.

Because HRT and tirzepatide act through complementary mechanisms, the combination addresses both the hormonal drivers and the metabolic drivers of menopausal weight gain simultaneously. Preclinical research suggests that oestrogen may enhance GLP-1 receptor signalling in the brain, which could partly explain the synergistic weight-loss effect observed in clinical data.

What the 2026 Lancet Study Found

A retrospective cohort study published in The Lancet Diabetes and Endocrinology in early 2026 examined approximately 120 postmenopausal women with overweight or obesity. The women using both tirzepatide and HRT achieved a mean total body weight loss of 19.2%, compared with 14.0% in the tirzepatide-only group. That represents roughly 35% greater weight loss in the combination group.

It is important to note that this was an observational study, not a randomised controlled trial. The authors acknowledged that women who actively seek HRT may be more health-conscious overall, which introduces selection bias. Nevertheless, the magnitude of the difference and the biological plausibility of oestrogen enhancing GLP-1 receptor activity make this a clinically significant finding that warrants further investigation through prospective trials.

The Absorption Question: Oral HRT and Gastric Emptying

Tirzepatide slows gastric emptying, particularly during the first few weeks and after each dose increase. Pharmacokinetic studies using paracetamol as a marker have shown that peak drug concentration (Cmax) can fall by up to 50% and time to peak (Tmax) can be delayed by approximately one hour after the first 5 mg dose, although total drug exposure (AUC) is generally preserved.

For oral contraceptives, tirzepatide has been shown to reduce the bioavailability of ethinyl oestradiol and norgestimate. This is why the MHRA and the manufacturer advise women taking oral hormonal contraceptives to use a barrier method for four weeks after starting tirzepatide and after each dose escalation.

Although no direct pharmacokinetic study has examined oral oestradiol HRT with tirzepatide, the same mechanism applies. Oral oestradiol passes through the stomach before absorption, so delayed gastric emptying could reduce its peak levels. For most women, this is unlikely to eliminate the therapeutic benefit of HRT entirely, but it could attenuate symptom control during dose changes.

Transdermal HRT preparations, including patches, gels, and sprays, are absorbed directly through the skin into the bloodstream. They bypass the gastrointestinal tract completely and are therefore unaffected by tirzepatide’s gastric-emptying effects. For this reason, many prescribers consider transdermal HRT the preferred option for women starting Mounjaro.

Practical Guidance for Women on Both Treatments

If you are currently taking oral HRT and plan to start Mounjaro, discuss with your prescriber whether switching to a transdermal preparation is appropriate. This eliminates the absorption uncertainty entirely.

If you prefer to continue with oral HRT, monitor your menopausal symptoms closely during the first four weeks after starting tirzepatide and after each dose escalation. A return of hot flushes, night sweats, or mood changes could indicate reduced oestrogen absorption. Report any symptom changes to your prescriber promptly.

Additionally, keep your Mounjaro injection day and your HRT routine consistent. Taking oral HRT at a time when tirzepatide’s gastric-emptying effect is weakest (typically five to seven days after injection) may help, although this has not been formally studied. Your prescriber can advise on timing based on your individual regimen.

If you are interested in understanding how your body composition is changing during treatment, a body composition DEXA scan at DEXA London, CutKilo’s sister service at the same 86 Harley Street clinic, can show precisely how much fat versus lean mass you are losing. This is especially useful during menopause, when preserving muscle mass is a clinical priority.

Safety Considerations

Both tirzepatide and HRT have their own side-effect profiles, and using them together does not appear to create new safety concerns beyond the absorption interaction described above. The most common tirzepatide side effects (reduced appetite, occasional digestive discomfort, and injection-site reactions) are not worsened by HRT.

HRT carries a small increased risk of venous thromboembolism (VTE), particularly with oral preparations. Obesity itself is an independent risk factor for VTE. As tirzepatide produces significant weight loss, it may over time reduce this background VTE risk, although this has not been studied in a dedicated trial. Transdermal HRT carries a lower VTE risk than oral HRT regardless of body weight, which is another reason it may be the preferred choice for women with obesity.

If you have a personal or family history of breast cancer, discuss the risks and benefits of HRT with your specialist before combining it with any weight-management treatment. The decision to use HRT is separate from the decision to use tirzepatide, and each should be assessed on its own clinical merits.

Frequently Asked Questions

Will Mounjaro stop my HRT from working? It is unlikely to eliminate HRT’s benefit entirely, but oral HRT absorption may be reduced during the early weeks of tirzepatide treatment and after dose increases. Switching to a patch, gel, or spray removes this concern completely.

Do I need to change my HRT dose when starting Mounjaro? Not automatically. Monitor your symptoms and speak to your prescriber if menopausal symptoms return. A switch to transdermal delivery is usually more effective than increasing the oral dose.

Is the 35% extra weight loss guaranteed? No. The 2026 Lancet study was observational, and individual responses vary considerably. The finding is encouraging and biologically plausible, but it has not been confirmed in a randomised trial.

Can I start HRT and Mounjaro at the same time? It is generally better to stabilise one treatment before adding the other, so your prescriber can identify which treatment is responsible for any side effects. In practice, many women are already established on HRT before starting tirzepatide.

Does Mounjaro affect progesterone absorption too? Progesterone taken orally could theoretically be affected by the same gastric-emptying mechanism. If you take a combined HRT preparation (oestrogen plus progesterone) in tablet form, discuss the option of switching to a transdermal oestrogen plus a Mirena coil or micronised progesterone capsule with your prescriber.

The Bottom Line

Tirzepatide and HRT can be used together safely, and emerging evidence suggests the combination may produce meaningfully better weight-loss outcomes than tirzepatide alone. The key practical consideration is the delivery method of your HRT. Transdermal preparations are unaffected by tirzepatide’s gastric-emptying effects, while oral HRT may have reduced absorption during dose-escalation phases. A conversation with your prescriber about switching to a patch, gel, or spray is the single most useful step you can take before starting Mounjaro for menopausal weight management.

Start Your CutKilo Journey

CutKilo is a doctor-led supervised Mounjaro weight-loss service based at 86 Harley Street, London W1G 7HP. Call: 0207 637 8227. Start the CutKilo questionnaire to see if you are suitable for treatment.

BMI Calculator

*If you have an Asian, Chinese, Middle Eastern, Black African or African-Caribbean family background:

  • 23 to 27.4 – overweight
  • 27.5 or above – obese

Have a question?

Our services are not intended for use in a medical emergency.

If you need urgent medical attention, please call 111 or 999

General Form

Site General Contact Form

Name(Required)

Patient Reviews

Posted on Google Google
gabriella farias profile picture
gabriella farias
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
Great customer service and advice threw out. So happy with everything and my results . Highly recommend 🙂
Posted on Google Google
Teresa Costa profile picture
Teresa Costa
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
Great advice, results and patience to respond to questions on time at anytime! Super recommend!
Posted on Google Google
Kristen profile picture
Kristen
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
Cannot recommend CutKilo highly enough. The doctor is genuinely lovely, warm, attentive, and has the kind of bedside manner that's increasingly rare. He takes the time to actually listen, explains everything clearly, and never makes you feel rushed or like just another number. There's no judgment, no pressure, just thoughtful, personalised care. And the treatment truly works. I've seen real, steady, sustainable results, and the ongoing support throughout has made all the difference. The whole experience has been discreet, professional, and genuinely transformative. If you're considering a medically supervised approach to weight management, you're in the safest possible hands here.
Posted on Google Google
Lilly K Photography profile picture
Lilly K Photography
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
Dr Emil is amazing , I highly recommend ! His support, kindness and motivation make a huge difference during my journey and he’s always available to answer any questions and help! Thank you again for everything!
Posted on Google Google
Arina Tetera profile picture
Arina Tetera
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
Highly recommend CutKilo if you are considering going on a GLP-1 journey. Very personal doctor-supervised service that helps lose weight more effectively and sustainably. I had my individual dose adjustment according to my needs and was also offered the option to come in at the Harley Street clinic for a free DEXA body composition scan. For me as a fitness professional this level of care stands out in a field that can be quite standardised in other places.
Posted on Google Google
MILKO MIRCHEV profile picture
MILKO MIRCHEV
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
I had a great experience with CutKilo – Medical Weight Loss. The support throughout my weight loss journey was excellent, and the program was both effective and well-structured. A special thank you to Dr. Emil, who was incredibly helpful, professional, and supportive at every step. He took the time to answer all my questions and made sure I felt confident and motivated throughout the process. Thanks to their guidance, I was able to successfully lose weight, and I truly appreciate the care and attention I received. I highly recommend CutKilo to anyone looking for a reliable and supportive medical weight loss program.
Posted on Google Google
Christopher Hardman profile picture
Christopher Hardman
Google star 1Google star 2Google star 3Google star 4Google star 5Trustindex verifies that the original source of the review is Google.
I was recommended to Dr Emil and the Cut Kilo group and am so glad I did. I was anxious about the weight loss journey but have been helped and reassured all the way. They are always there to help and the follow up support from Hannah the nutritionist and Dr Emily have been excellent. Would thoroughly recommend